The Agency for Healthcare Research and Quality (AHRQ) today announced new support for assessing and improving the U.S. health care system's capacity to respond to possible incidents of bioterrorism. This $5 million initiative, focusing on clinical preparedness of health care providers and health care systems, is part of a broad effort by the U.S. Department of Health and Human Services and other federal agencies against bioterrorism.
In other public health news, health professionals in the public arena are sure to field questions regarding the influenza vaccine. Be prepared with this excellent hand out from the CDC. After all, flu season is just around the corner.
Many people with uncomplicated influenza use over-the-counter medicines to help lessen their symptoms. Antiviral drugs can also help to reduce the time it takes for symptoms to improve in uncomplicated illness caused by influenza virus. Recent increases in the number and promotion of antiviral drugs for influenza have increased interest in the role of specific antiviral drugs for this condition. Get the information you need regarding these antiviral drugs in today's Vidyya.
The World Health Organization (WHO) is coordinating an international response to an outbreak of haemorrhagic fever in Gulu District, northern Uganda. As of 17 October 2000, 81 cases, including 35 deaths, have been reported. Cases were first reported in a local hospital in Gulu town and are now occurring in the community.
Ebola haemorrhagic fever (EHF) is one of the most virulent viral diseases known to humankind, causing death in 50-90% of all clinically ill cases. The disease has its origins in the jungles of Africa and Asia. Several different forms of Ebola virus have been identified and may be associated with other clinical expressions, on which further research is required. Learn more about this deadly fever with a fact sheet available in today's issue.
The articles in today's Vidyya are:
As always, we hope you enjoy the issue.